Berberine is a plant compound best known for its role in metabolic health. Research suggests it may help support healthy blood sugar levels, cholesterol balance, and insulin sensitivity.
Yet despite its popularity, berberine has one well-known limitation: the body absorbs relatively little of it after ingestion.
Liposomal berberine was developed to address that problem. It does not change the active ingredient; it changes how berberine is delivered. For people already using berberine for metabolic support, the delivery format may be worth a closer look.
What Is Liposomal Berberine?
“Liposomal” refers to a delivery system that encapsulates berberine within microscopic particles called liposomes. These structures help protect berberine during digestion and are designed to improve how much reaches circulation.
The active ingredient remains the same. The difference is how it is delivered.
What Is the Liposomal Carrier Made From?
Liposomes are typically made from phospholipids, fat-like molecules that form the outer membranes of cells. In supplements, these phospholipids create a protective shell around berberine, helping transport it through the digestive process.
Phospholipids are commonly sourced from soy or sunflower, although some formulations use plant-derived alternatives such as ginsenosides.
What the Research Shows
Research on liposomal berberine is still limited, but one small human study gives a useful comparison. In a recent randomised controlled trial, researchers gave healthy males the same dose of liposomal and standard berberine, then measured how much reached the bloodstream.
The liposomal form resulted in 70.1% higher peak blood levels and 42.8% greater overall exposure over 24 hours (3). In practical terms, the same amount of berberine produced noticeably higher levels in circulation when delivered in a liposomal format. The trial was small, and long-term effects remain to be studied.
On dose, reviews of clinical trials commonly report standard berberine intakes between 500 mg and 1,500 mg per day, often split across meals (1, 2). Studies using 1,000 mg and 1,500 mg daily have reported improvements in markers linked to blood sugar and cholesterol management (4, 5).
This helps explain why standard berberine research often relies on moderate to higher daily doses, while liposomal berberine is being studied for whether more can reach circulation from the same amount.
Learn more in our previous articles: Berberine - Health Benefits, Dosage and Side Effects Are Liposomal Formulations of Supplements Better? How does our diet influence the bioavailability of supplements?
How Much Should You Take?
Clinical research on standard berberine has typically used 500 mg to 1,500 mg per day, split across two or three servings with meals (1, 2). Higher daily doses are more often used in studies looking at blood sugar and cholesterol outcomes.
With liposomal berberine, the dose discussion shifts. Because more of what you take appears to reach circulation, a lower amount may still provide meaningful exposure.
A Few Practical Points
- Starting with 250 mg active berberine may allow the body to adjust. Digestive discomfort and nausea are among the most common early side effects and may be dose-dependent.
- Once tolerance is established, 500 mg active berberine is a practical lower-end starting point. It aligns with the lower end of the range reported in standard berberine research, while using a format designed for better absorption.
- Check the label for the active berberine figure, not just the total liposomal berberine hydrochloride weight. Both are often listed, and the active amount gives the clearest picture of what you are taking.
- Berberine can interact with certain medications and is not recommended during pregnancy or breastfeeding unless advised by a healthcare professional.
Augment Life offers a wide range of liposomal supplements. More information about some of them can be found here: Liposomal Berberine, Liposomal Resveratrol, Liposomal NR, Liposomal NMN, Liposomal Bundle
The Takeaway
The strongest evidence for liposomal berberine is not that it works differently from standard berberine, but that more of it appears to reach circulation from the same dose.
For people who already use berberine for metabolic support, that may be reason enough to consider the liposomal format.
The decision comes down to whether improved absorption, convenience, and potentially lower-dose efficiency are worth the extra cost.
Literature Sources
- Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G. Meta-Analysis of the Effect and Safety of Berberine in the Treatment of Type 2 Diabetes Mellitus, Hyperlipemia and Hypertension. Journal of Ethnopharmacology. 2015;161:69–81. DOI: 10.1016/j.jep.2014.09.049
- Dong H, Wang N, Zhao L, Lu F. Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine. 2012;2012:591654. DOI: 10.1155/2012/591654
- Purpura M, Jäger R, Godavarthi A, Ceylan Hİ, Chandrappa A, Tinsley GM. Liposomal Delivery as a Strategy to Improve Berberine Bioavailability: A Double-Blind, Crossover, Randomized Pilot Study in Healthy Males. Nutrition and Dietary Supplements. 2026;18:41–50. DOI: 10.2147/NDS.S582434
- Zhang Y, Li X, Zou D, et al. Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine. Journal of Clinical Endocrinology & Metabolism. 2008;93(7):2559–2565. DOI: 10.1210/jc.2007-2404
- Yin J, Xing H, Ye J. Efficacy of Berberine in Patients with Type 2 Diabetes Mellitus. Metabolism. 2008;57(5):712–717. DOI: 10.1016/j.metabol.2008.01.013
